[1]李岳飞朱丹丹张晓燕王学军高关心白飞林夏.心脏介入药物涂层球囊临床使用合理性评价及干预研究[J].中国卫生质量管理,2021,28(07):014-17.[doi:10.13912/j.cnki.chqm.2021.28.7.04 ]
　LI Yuefei,ZHU Dandan,ZHANG Xiaoyan.Rationality Evaluation of Clinical Use and Intervention Study of Drug Coated Balloon for Cardiac Intervention[J].Chinese Health Quality Management,2021,28(07):014-17.[doi:10.13912/j.cnki.chqm.2021.28.7.04 ]
点击复制

心脏介入药物涂层球囊临床使用合理性评价及干预研究
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第28卷
期数:
2021年07期
页码:
014-17
栏目:
特别关注
出版日期:
2021-07-28

文章信息/Info

Title:
Rationality Evaluation of Clinical Use and Intervention Study of Drug Coated Balloon for Cardiac Intervention
作者:
李岳飞朱丹丹张晓燕王学军高关心白飞林夏
内蒙古自治区人民医院
Author(s):
LI Yuefei; ZHU Dandan; ZHANG Xiaoyan
Inner Mongolia People's Hospital, Hohhot
关键词:
医院卫生技术评估; 心脏介入; 药物涂层球囊; 合理性评价
Keywords:
Hospital Based Health Technology Assessment;  Cardiac Intervention;  Drug Coated Balloon;  Evaluation of Rationality
分类号:
R197.39
DOI:
10.13912/j.cnki.chqm.2021.28.7.04
文献标志码:
A
摘要:
目的对某三级医院心脏介入药物涂层球囊的临床使用情况进行分析，评价其临床使用合理性。方法参考HB-HTA评价维度，从安全性、有效性、经济性3个方面制定评价指标体系，通过与药物洗脱支架进行对比，评价药物涂层球囊临床使用合理性，并将评价结果应用于管理决策。结果该药物涂层球囊临床使用有效性与药物洗脱支架基本一致，经济性具有一定优势，但在安全性方面有71.1％的病例存在未按说明书使用情况。制定改进措施并实施后，药物涂层球囊未按说明书使用病例比例由69%降为0%，同时患者人均药物涂层球囊费用由23 203.1元降至20 350.0元。结论医院开展医用耗材临床合理使用管理工作时，可参考HB-HTA模式，建立临床使用合理性评价指标体系，并进行定期评价，为管理决策提供依据，以提升医院耗材管理水平。
Abstract:
ObjectiveTo analyze the clinical application of drug-coated balloon for cardiac intervention in a tertiary hospital, and to evaluate the rationality of its clinical application. MethodsBased on evaluation dimensions of the HB-HTA, an evaluation index system was established from three aspects of safety, effectiveness and economy. By comparing with drug-eluting stents, the rationality of clinical use of drug-coated balloon was evaluated, and the evaluation result was applied to management decisions.ResultsThe clinical efficacy of the drug coated balloon for cardiac intervention was similar to that of the drug eluting stent, and it had some advantages in economy. However, in terms of safety, 71.1% of the patients did not use the balloon according to the instructions. After the improvement measures were developed and implemented, the proportion of patients who did not use drug coated balloon according to the instructions decreased from 69% to 0%, and the cost of drug coated balloon per patient decreased from 23 203.1 yuan to 20 350.0 yuan.Conclusion The HB-HTA mode can be used as reference to establish the evaluation index system for the rationality of clinical use in the management of medical consumables. Regular evaluation can be carried out to support the management decision and improve the management level of hospital consumables.

参考文献/References:

［1］林夏,白飞,吕兰婷,等.中国医院卫生技术评估试点成效及推进策略［J］.中国循证医学杂志,2020,20(1):94-97. ［2］林夏,吕兰婷,金盾,等.在我国推广医院卫生技术评估的可行性分析［J］.中国医院管理,2019,39(2):11-13. ［3］杨海.医院卫生技术评估在医用耗材管理中的应用［J］.中国医疗设备,2017,32(5):123-126. ［4］杨坤,吴晓芬,邵蕾.基于大型设备日志分析的卫生技术评估及应用［J］.外科研究与新技术,2019,8(3):205-207. ［5］魏巍,张涛,鱼敏.便携式早期清创冲洗器的卫生技术评估［J］.中国卫生质量管理,2018,25(3):79-81. ［6］唐檬,陈英耀,茅艺伟,等.中国卫生技术评估决策转化现状及影响因素的定性研究［J］.中国卫生质量管理,2015,22(1):61-64. ［7］Myeong-Ki，Seung-Yul H.Differential effects of drug-coated balloon angioplasty for in-stent restenosis［J］.Journal of the American College of Cardiology,2020,82(2):2679-2681. ［8］Stella PR,Belkacemi A，Dubois C,et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus baremetal stent versus drug-eluting stent in bifurcation lesions terated with a single-stenting technique:six-month angiographic and 12-month clinical results of the drug-eluting balloon inbifu-rcations trial［J］.Catheter Cardiovasc Interv, 2012,80(7):1138-1146. ［9］蒋金法,刘 洋.药物涂层球囊在冠状动脉分叉病变中的应用前景［J］.外科研究与新技术，2014,3(4):225-227. ［10］闫冰.按必要性支架植入术原则应用紫杉醇药物涂层球囊治疗冠状动脉分叉病变［D］.长春：吉林大学，2016. ［11］杨颖.球囊支架对吻术在冠状动脉分叉病变介入治疗的Meta分析［D］.重庆：重庆医科大学，2019. ［12］曹斌,盘兰萍,蒋柏枫,等.拘禁球囊技术在冠状动脉分叉病变介入治疗中有效性的Meta分析［J］.临床荟萃，2018,33(11):978-981. ［13］谢江波，陈晖，衷涛，等.药物涂层球囊在冠状动脉分叉病变中的应用［J］.心血管病学进展，2019,40(2):246-248. ［14］李今朝，张军，屈宝泽，等.冠心病介入治疗指南与医生的理解、掌握与运用的冲突和平衡［J］.医学与哲学(B)，2014,35（4）：4-7. ［15］蒋芳勇，韦金儒.药物洗脱支架时代冠状动脉分叉病变的介入治疗［J］.微创医学,2013,8(1):78-81.

相似文献/References:

[1]罗莉许媛媛房良李志建杨海郑蕴欣李斌.基于全面质量管理理论构建城市医疗集团HB-HTA小组的论证[J].中国卫生质量管理,2023,30(07):078.[doi:10.13912/j.cnki.chqm.2023.30.7.17 ]
　LUO Li,XU Yuanyuan,FANG Liang.Establishment of HB-HTA Team of Urban Medical Group Based on Total Quality Management Theory[J].Chinese Health Quality Management,2023,30(07):078.[doi:10.13912/j.cnki.chqm.2023.30.7.17 ]
[2]林海蓓刘昕罗莉郑蕴欣罗力金春林王海银.基于多准则决策分析的公立医院高值医用耗材准入指标及权重研究[J].中国卫生质量管理,2023,30(11):064.[doi:10.13912/j.cnki.chqm.2023.30.11.14 ]
　LIN Haibei,LIU Xin,LUO Li.Access Indicators and Weights of High-Value Medical Consumables in Public Hospitals Based on Multi-Criteria Decision Analysis[J].Chinese Health Quality Management,2023,30(07):064.[doi:10.13912/j.cnki.chqm.2023.30.11.14 ]
[3]钱萍 吴英 金辉.阿根廷儿童专科医院卫生技术评估应用及启示[J].中国卫生质量管理,2024,31(05):068.[doi:10.13912/j.cnki.chqm.2024.31.5.16]
　QIAN Ping,WU Ying,JIN Hui.Application and Implications of Hospital-Based Health Technology Assessment in Children’s Specialty Hospital in Argentina[J].Chinese Health Quality Management,2024,31(07):068.[doi:10.13912/j.cnki.chqm.2024.31.5.16]
[4]钱萍 李瑶 吴英.意大利医院卫生技术评估组织模式与运行机制分析及启示[J].中国卫生质量管理,2024,31(06):086.[doi:10.13912/j.cnki.chqm.2024.31.6.17]
　QIAN Ping,LI Yao,WU Ying.Organizational Mode and Operating Mechanism of Hospital Based Health Technology Assessment in Italy[J].Chinese Health Quality Management,2024,31(07):086.[doi:10.13912/j.cnki.chqm.2024.31.6.17]
[5]耿劲松 唐密 杨海 金春林 何江江.医院卫生技术评估研究方法的循证分析[J].中国卫生质量管理,2024,31(12):001.[doi:10.13912/j.cnki.chqm.2024.31.12.01]
　GENG Jinsong,TANG Mi,YANG Hai.Evidence-Based Analysis of Research Methods for Hospital-Based Health Technology Assessment[J].Chinese Health Quality Management,2024,31(07):001.[doi:10.13912/j.cnki.chqm.2024.31.12.01]
[6]唐密 杨海 耿劲松 王海银 王月强 杨燕 胡善联 金春林 何江江.我国医院卫生技术评估通用要求研究[J].中国卫生质量管理,2024,31(12):007.[doi:10.13912/j.cnki.chqm.2024.31.12.02]
　TANG Mi,YANG Hai,GENG Jinsong.Research on General Requirements of Hospital-Based Health Technology Assessment in China[J].Chinese Health Quality Management,2024,31(07):007.[doi:10.13912/j.cnki.chqm.2024.31.12.02]
[7]罗莉 许媛媛 刘义成 徐桔密 尚文茹 李小利 郑蕴欣 杨海.供需适配视域下我国医院卫生技术评估现状及策略研究[J].中国卫生质量管理,2024,31(12):012.[doi:10.13912/j.cnki.chqm.2024.31.12.03]
　LUO Li,XU Yuanyuan,LIU Yicheng.Research on the Current Situation and Strategy of Hospital-Based Health Technology Assessment in China from the Perspective of Supply and Demand Adaptability[J].Chinese Health Quality Management,2024,31(07):012.[doi:10.13912/j.cnki.chqm.2024.31.12.03]
[8]李小利 尚文茹 罗莉 杨海.医院卫生技术评估在临床专科能力建设中的实践与思考[J].中国卫生质量管理,2024,31(12):017.[doi:10.13912/j.cnki.chqm.2024.31.12.04]
　LI Xiaoli,SHANG Wenru,LUO Li.Practice and Thinking of Hospital-Based Health Technology Assessment in Clinical Specialty Capacity Building[J].Chinese Health Quality Management,2024,31(07):017.[doi:10.13912/j.cnki.chqm.2024.31.12.04]
[9]吕兰婷 施文凯 唐佳骥 赵玉凤.中医医院开展医院卫生技术评估的需求与策略研究[J].中国卫生质量管理,2024,31(12):022.[doi:10.13912/j.cnki.chqm.2024.31.12.05]
　LYU Lanting,SHI Wenkai,TANG Jiaji.Study on the Needs and Strategies of Hospital-Based Health Technology Assessment in Traditional Chinese Medicine Hospitals[J].Chinese Health Quality Management,2024,31(07):022.[doi:10.13912/j.cnki.chqm.2024.31.12.05]

更新日期/Last Update: 2021-07-28